NCT01523184View on ClinicalTrials.gov

A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Chronic ConstipationFunctional Constipation
Interventions
DRUG

Placebo Capsule

This is the placebo capsule

DRUG

YKP10811 Drug Product Capsule

The drug product, YKP10811, 10 mg under investigation

DRUG

YKP10811 Drug Product Capsule

The drug product, YKP10811, 20 mg under investigation

DRUG

YKP10811 Drug Product Capsule

The drug product, YKP10811, 30 mg under investigation

Trial Locations (1)

55905

Mayo Clinic, Rochester

All Listed Sponsors
lead

SK Life Science, Inc.

INDUSTRY

NCT01523184 - A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation | Biotech Hunter | Biotech Hunter